Saturday, September 15, 2018

Candidates for neuroprotective trials

1. Hypothermia
2. Caspace inhibitors (none tried yet due to irreversibility)
3. Hypoxic preconditioning (how would this study be done?)
4. Magnesium antiexcitotoxin, inhibits inflammation, reduces infarct volume six hours late
5. Minocycline
6. Enlimomab
7. FK506
8.

No comments: